Srivastava / Vatsa | Targeted Radiopharmaceuticals and Imaging | Buch | 978-1-83767-327-8 | www.sack.de

Buch, Englisch, 480 Seiten, Format (B × H): 158 mm x 236 mm, Gewicht: 906 g

Srivastava / Vatsa

Targeted Radiopharmaceuticals and Imaging

Development Challenges and Opportunities
1. Auflage 2025
ISBN: 978-1-83767-327-8
Verlag: Royal Society of Chemistry

Development Challenges and Opportunities

Buch, Englisch, 480 Seiten, Format (B × H): 158 mm x 236 mm, Gewicht: 906 g

ISBN: 978-1-83767-327-8
Verlag: Royal Society of Chemistry


Targeted radiopharmaceutical therapy (RPT) is emerging as an innovative approach for treating a wide range of cancers.

Almost all radionuclides used in RPT emit photons that can be imaged, enabling non-invasive visualization of the therapeutic agent's biodistribution. The remarkable potential of radiopharmaceutical therapy is now being recognized with recent FDA approval of several RPT drugs and a significant number of drug candidates in clinical development.

This book offers a comprehensive perspective on the different technologies and addresses the critical challenges in developing and commercializing radiopharmaceuticals. It covers various topics, from clinical applications to specific radiopharmaceutical biodistribution, dosimetry, and novel targets in oncology. The chapters provide a cohesive picture of the advances in SPECT/CT and PET/CT imaging, clinical trends in targeted therapies utilizing radioisotopes for cancer imaging, and clinical applications of radiotracers within oncology areas. It also delves into the manufacturing technologies and regulatory and supply logistics required to support the development of the next wave of targeted alpha therapies.

This resource is ideal for postgraduates and researchers in drug discovery and development in radionuclide therapy and imaging in cancer, as well as medical professionals engaged in nuclear medicine and radiology.

Srivastava / Vatsa Targeted Radiopharmaceuticals and Imaging jetzt bestellen!

Weitere Infos & Material


Targeted Radiopharmaceuticals: Clinical Development and Commercial Landscape

Advances in Targeted Radiopharmaceuticals: Challenges and Opportunities

Alpha-particle Emitting Radiopharmaceuticals in Targeted Therapy and Diagnostics: Challenges and Opportunities

Chelator Design and Radiolabeling Chemistry of Radiometals

Dosimetry Methods for Radiopharmaceuticals

Glypican-3 (GPC3) Targeted Radiopharmaceuticals for Treatment of Liver Cancer

Identifying New Molecular Modalities for Radionuclide Therapy Using Macrocyclic Peptide Mimetics

Peptides and Small Radiopharmaceuticals for Molecular Targeting

Antibody Based Radiopharmaceuticals in Clinical Development

Prostate-specific Membrane Antigen Targeted Prostate Imaging and Therapy

Radiotracers for Imaging of Breast Cancer and Targeted Radionuclide Therapy

Neuroendocrine Tumors: Radiopharmaceuticals for Imaging and Therapy

Radiopharmaceuticals for Imaging and Therapy in Neurology

Thyroid Imaging and Radionuclide Therapy

Radiopharmaceuticals for Skeletal Imaging and Therapy

Radiopharmaceuticals in Dermatologic Imaging and Therapy

Targeted Radiopharmaceuticals for Infection Imaging

Manufacturing Challenges and Radiopharmaceutical Application of 18F-labeled Heterocycles for PET Imaging

Quality Considerations in Radiopharmaceuticals



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.